Emily Field, head of European pharmaceuticals research at Barclays, weighs in on rising competition in the global obesity ...
Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...
Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...
The company states the acquisition will further MERIT’s service offerings, allowing for a seamless transition from ...
Medical Xpress on MSN9d
Study Finds Three New Safe, Effective Ways To Treat Drug-Resistant TuberculosisA third drug, pretomanid, received emergency authorization from the FDA for specific use within a regimen against highly drug ...
II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, ...
Launch of Hyde Park Discovery between UChicago, Deerfield Management to accelerate research into life-saving treatments ...
A high-resolution spatial map of the human hypothalamus makes it possible to identify specific cells, determine their exact ...
As one of the largest tuberculosis outbreaks in the U.S. unfolds in Kansas, UC San Diego researchers and their colleagues ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback